A deadly fungus has already wiped out 90 species and threatens 500 more but Anthony Waddle is hoping gene replacement could be their salvation ...

Sentynl Therapeutics Inc. ("Sentynl"), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences Limited ...

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics ...

A ₹3.5 crore Madhya Pradesh-funded study on cow dung and urine as cancer treatment raises questions over scientific validity, ...

As the calendar flips to a new year, so do the lives of countless pets in East Texas — leaving shelter cages behind for warm ...

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium Cyprium eligible to receive tiered royalties and up to $129 milli ...

Almost 200 new plants and fungi were named new to science last year, with conservationists warning that many are already ...

For the first time, scientists have answered a longstanding question in cell biology about a partnership of proteins called the "KICSTOR-GATOR1 complex" which operate as a control system inside our ...

By identifying the causes of a rare condition known as auto-brewery syndrome (ABS), scientists can perfect methods for ...

Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, today announced that 11 new programs entered clinical trials in 2025. These 11 ...

In silico antibody accessibility analysis indicates that ectodomain epitopes are transiently exposed, while MPER epitopes are virtually always occluded in the pre-fusion trimer.